title: Regulation of actin ring formation by rho GTPases in osteoclasts.
abstract: Actin ring formation is a prerequisite for osteoclast bone resorption. Although gelsolin null osteoclasts failed to exhibit podosomes, actin ring was observed in these osteoclasts. Wiscott-Aldrich syndrome protein (WASP) was observed in the actin ring of gelsolin null osteoclast. Osteoclasts stimulated with osteopontin simulated the effects of Rho and Cdc42 in phosphatidylinositol 4,5-bisphosphate (PIP2) association with WASP as well as formation of podosomes, peripheral microfilopodia-like structures, and actin ring. To explore the potential functions of Rho and Cdc42, TAT-mediated delivery of Rho proteins into osteoclasts was performed. Although Rho and Cdc42 are required for actin ring formation, transduction of either one of the proteins alone is insufficient for this process. Addition of osteopontin to osteoclasts transduced with Cdc42Val12 or transduction of osteoclasts with both RhoVal14 and Cdc42Val12 augments the formation of WASP-Arp2/3 complex and actin ring. Neomycin, an antibiotic, blocked the effects of osteopontin or TAT-RhoVal14 on PIP2 interaction with WASP. WASP distribution was found to be cytosolic in these osteoclasts. Depletion of WASP by short interfering RNA-mediated gene silencing blocked actin polymerization as well as actin ring formation in osteoclasts. These results suggest that Rho-mediated PIP2 interaction with WASP may contribute to the activation and membrane targeting of WASP. Subsequent interaction of Cdc42 and Arp2/3 with WASP may enhance cortical actin polymerization in the process of actin ring formation in osteoclasts.
authors: Department of Biomedical Sciences, Dental School, University of Maryland, Baltimore, Maryland 21201, USA. mac001@dental.umaryland.edu
authors: Meenakshi A
authors: MA
authors: Chellaiah
mesh_terms: D000199:Actins / Q000737:chemistry / Q000378:metabolism*; D000818:Animals; D015153:Blotting, Western; D001862:Bone Resorption; D002855:Chromatography, Thin Layer; D003600:Cytosol / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D018260:Gelsolin / Q000737:chemistry; D005786:Gene Expression Regulation; D020868:Gene Silencing; D015151:Immunoblotting; D007150:Immunohistochemistry; D047468:Immunoprecipitation; D051379:Mice; D009355:Neomycin / Q000494:pharmacology; D010010:Osteoclasts / Q000201:enzymology* / Q000378:metabolism; D053495:Osteopontin; D019269:Phosphatidylinositol 4,5-Diphosphate / Q000378:metabolism; D010716:Phosphatidylinositols / Q000737:chemistry; D011485:Protein Binding; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D011554:Pseudopodia / Q000378:metabolism; D012313:RNA / Q000378:metabolism; D034741:RNA, Small Interfering / Q000378:metabolism; D011994:Recombinant Proteins / Q000737:chemistry; D012795:Sialoglycoproteins / Q000737:chemistry / Q000378:metabolism; D015398:Signal Transduction; D020764:cdc42 GTP-Binding Protein / Q000378:metabolism; D020741:rho GTP-Binding Proteins / Q000502:physiology*
chemical_list: D000199:Actins; D018260:Gelsolin; D019269:Phosphatidylinositol 4,5-Diphosphate; D010716:Phosphatidylinositols; D011500:Protein Synthesis Inhibitors; D034741:RNA, Small Interfering; D011994:Recombinant Proteins; D012795:Sialoglycoproteins; C506896:Spp1 protein, mouse; D053495:Osteopontin; D012313:RNA; D020764:cdc42 GTP-Binding Protein; D020741:rho GTP-Binding Proteins; D009355:Neomycin